AbbVie Inc. (NYSE:ABBV) earnings reaction history

AbbVie Inc. (NYSE:ABBV) is projected to declare fiscal first quarter financial results right before the stock market’s official open on April 28, 2017. The stock added about 7.5 percent in price since last results when it was at $61.27 a share. Based on the most relevant past-periods data, there is an 50 percent probability for this firm’s share price to go up following next quarterly results. Earnings reaction history tells us that the equity price moved up 8 times out of last 16 reported quarters. It has beaten earnings-per-share estimates 75% of the time in its last 12 earnings reports. It fell short of earnings estimates on 0 occasions, and it has met expectations 3 times.

Here’s how traders responded to ABBV earnings announcements over the past few quarters.

AbbVie Inc. (ABBV) Earnings Surprises & Reaction

Given its history, the average earnings announcement surprise was 1.92 percent over the past four quarters. Back on January 27, 2017, it posted earnings per-share earnings at $1.2 which came in line with the consensus $1.2 projection (no surprise). For the quarter, revenue came in at 6.78B versus consensus estimate of 6.91B. The stock dropped -2.07 percent the session following the earnings reports were released, and on 7th day price change was -0.62 percent.

On October 28, 2016, it reported earnings at $1.21 a share compared with the consensus estimate of $1.21 per share (negative surprise of 0%). Revenue of 6.39B for that quarter was below the $6.56B analysts had expected. The stock retreated -6.28% the day following the earnings announcement, and on 7th day price change was -9.06%.

On July 29, 2016, it recorded $1.26 a share in earnings which topped the consensus estimate of $1.2 (positive surprise of 5%). Revenue for the quarter was $6.43B while analysts called for revenues to be $6.2B. The stock gained 2.34% the day following the earnings data was made public, and on 7th day price change was 2.14%.

On April 28, 2016, it announced earnings per share at $1.15 versus the consensus estimate of $1.12 per share (positive surprise of 2.68%). That came on revenues of $5.96B for that period. Analysts had expected $5.97B in revenue.

AbbVie Inc. Earnings Estimates

As Q1 earnings announcement date approaches, Wall Street is expecting earnings per share of $1.26. The analysts’ present consensus range is $1.23-$1.32 for EPS. The market consensus range for revenue is between $6.38B and $6.56B, with an average of $6.47B.

AbbVie Inc. (NYSE:ABBV) last ended at $65.85, sending the company’s market cap near $104.96B. The consensus 12-month price target from analysts covering the stock is $70.11. The share price has declined -1.46% from its top level in 52 weeks and dropped 6.22% this year. It recently traded in a range of $65.3-$65.94 at a volume of 7089239 shares. The recent trading ended with the price nearly 3.62 higher for the last 5 trading days, rebounding 25.65% from its 52-week low.